SCHEMBL27420062

SCHEMBL27420062

CC(C)(C)N[C@@H](COC(C)(C)C)C(=O)C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.39
▸ GRN P28799 1/20 0.38
▸ SORT1 Q99523 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13166785 1.00 MAPK1 (0.39) MAPK1GRNSORT1
SCHEMBL20850028 1.00 MAPK1 (0.39) MAPK1GRNSORT1
SCHEMBL978016 0.82 GRN (0.49) MAPK1GRNSORT1
SCHEMBL978015 0.82 GRN (0.49) MAPK1GRNSORT1
SCHEMBL12252736 0.82 CA12 (0.31) —
Hydrochloric Acid SCHEMBL5226312 0.81 GRN (0.48) MAPK1GRNSORT1
SCHEMBL19546255 0.81 MAPK1 (0.43) MAPK1GRNSORT1
SCHEMBL27437691 0.81 MAPK1 (0.43) MAPK1GRNSORT1
SCHEMBL13755299 0.79 — —
SCHEMBL19544674 0.79 MAPK1 (0.42) MAPK1GRNSORT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240216526-A1 PREPARATION METHOD FOR DUAL-DRUG-LINKER OF ADC AND USE THEREOF CHENGDU SCIMOUNT PHARMATECH CO., LTD. (CN) 2024-07-04 — — US disclosed
US-20240216526-A1 PREPARATION METHOD FOR DUAL-DRUG-LINKER OF ADC AND USE THEREOF CHENGDU SCIMOUNT PHARMATECH CO., LTD. (CN) 2024-07-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240216526-A1 PREPARATION METHOD FOR DUAL-DRUG-LINKER OF ADC AND USE THEREOF SKP1, ADCY7, ERBB2 MAPK1 822/4885GRN 4701/4885SORT1 1719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback